BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rehman S, Goodacre R, Day PJ, Bayat A, Westerhoff HV. Dupuytren's: a systems biology disease. Arthritis Res Ther 2011;13:238. [PMID: 21943049 DOI: 10.1186/ar3438] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Rödel F, Fournier C, Wiedemann J, Merz F, Gaipl US, Frey B, Keilholz L, Seegenschmiedt MH, Rödel C, Hehlgans S. Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases. Front Immunol 2017;8:519. [PMID: 28515727 DOI: 10.3389/fimmu.2017.00519] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
2 Degreef I, Tejpar S, Sciot R, De Smet L. High-Dosage Tamoxifen as Neoadjuvant Treatment in Minimally Invasive Surgery for Dupuytren Disease in Patients with a Strong Predisposition Toward Fibrosis: A Randomized Controlled Trial. Journal of Bone and Joint Surgery 2014;96:655-62. [DOI: 10.2106/jbjs.l.01623] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
3 Shchudlo N, Varsegova T, Stupina T, Dolganova T, Shchudlo M, Shihaleva N, Kostin V. Assessment of palmar subcutaneous tissue vascularization in patients with Dupuytren’s contracture. World J Orthop 2018; 9(9): 130-137 [PMID: 30254969 DOI: 10.5312/wjo.v9.i9.130] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Eaton C. Evidence-Based Medicine: Dupuytren Contracture. Plastic and Reconstructive Surgery 2014;133:1241-51. [DOI: 10.1097/prs.0000000000000089] [Cited by in Crossref: 33] [Cited by in F6Publishing: 5] [Article Influence: 4.1] [Reference Citation Analysis]
5 Grazina R, Teixeira S, Ramos R, Sousa H, Ferreira A, Lemos R. Dupuytren's disease: where do we stand? EFORT Open Rev 2019;4:63-9. [PMID: 30931150 DOI: 10.1302/2058-5241.4.180021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Lurati AR. Dupuytren's Contracture. Workplace Health Saf 2017;65:96-9. [PMID: 28068478 DOI: 10.1177/2165079916680215] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
7 Chisholm J, Gareau AJ, Byun S, Paletz JL, Tang D, Williams J, LeVatte T, Bezuhly M. Effect of Compound 21, a Selective Angiotensin II Type 2 Receptor Agonist, in a Murine Xenograft Model of Dupuytren Disease. Plast Reconstr Surg 2017;140:686e-96e. [PMID: 29068929 DOI: 10.1097/PRS.0000000000003800] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
8 Ayers D, Day PJ. Systems Medicine: The Application of Systems Biology Approaches for Modern Medical Research and Drug Development. Mol Biol Int 2015;2015:698169. [PMID: 26357572 DOI: 10.1155/2015/698169] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
9 Rehman S, Xu Y, Dunn WB, Day PJ, Westerhoff HV, Goodacre R, Bayat A. Dupuytren's disease metabolite analyses reveals alterations following initial short-term fibroblast culturing. Mol Biosyst 2012;8:2274-88. [PMID: 22772395 DOI: 10.1039/c2mb25173f] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
10 Ghobadian Z, Ahmadi MR, Rezazadeh L, Hosseini E, Kokhazadeh T, Ghavam S. In Vitro Evaluation of Achillea Millefolium on the Production and Stimulation of Human Skin Fibroblast Cells (HFS-PI-16). Med Arch 2015;69:212-7. [PMID: 26543303 DOI: 10.5455/medarh.2015.69.212-217] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
11 Lee HH, Satish L. Biological Targets for Dupuytren Disease. Ann Plast Surg 2021;87:355-8. [PMID: 33587458 DOI: 10.1097/SAP.0000000000002739] [Reference Citation Analysis]
12 Yeh CC, Huang KF, Ho CH, Chen KT, Liu C, Wang JJ, Chu CC. Epidemiological profile of Dupuytren's disease in Taiwan (Ethnic Chinese): a nationwide population-based study. BMC Musculoskelet Disord 2015;16:20. [PMID: 25881036 DOI: 10.1186/s12891-015-0476-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
13 Vaughan MB, Odejimi TD, Morris TL, Sawalha D, Spencer CL. A new bioassay identifies proliferation ratios of fibroblasts and myofibroblasts: New myofibroblast proliferation bioassay. Cell Biol Int 2014;38:981-6. [DOI: 10.1002/cbin.10289] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
14 Verma M, Karimiani EG, Byers RJ, Rehman S, Westerhoff HV, Day PJ. Mathematical modelling of miRNA mediated BCR.ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies. Integr Biol (Camb) 2013;5:543-54. [PMID: 23340812 DOI: 10.1039/c3ib20230e] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
15 Novotny T, Eckhardt A, Knitlova J, Doubkova M, Ostadal M, Uhlik J, Musilkova J. Increased Microvessel and Arteriole Density in the Contracted Side of the Relapsed Clubfoot. J Pediatr Orthop 2020;40:592-6. [PMID: 32379245 DOI: 10.1097/BPO.0000000000001563] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Vaughan MB, Xu G, Morris TL, Kshetri P, Herwig JX. Predictable fibroblast tension generation by measuring compaction of anchored collagen matrices using microscopy and optical coherence tomography. Cell Adh Migr 2019;13:303-14. [PMID: 31331232 DOI: 10.1080/19336918.2019.1644855] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
17 Eftimie G, Eftimie R; Clinique de la Miotte, Avenue de la Miotte, Belfort 90000, France, Laboratoire Mathématiques de Besançon, UMR - CNRS 6623 Université de Bourgogne Franche-Comté, Besançon 25000, France. . MBE 2022;19:2876-95. [DOI: 10.3934/mbe.2022132] [Reference Citation Analysis]
18 Rehman S, Day PJ, Bayat A, Westerhoff HV. Understanding Dupuytren's Disease Using Systems Biology: A Move Away from Reductionism. Front Physiol 2012;3:316. [PMID: 22934066 DOI: 10.3389/fphys.2012.00316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Musumeci M, Vadalà G, Russo F, Pelacchi F, Lanotte A, Denaro V. Dupuytren's disease therapy: targeting the vicious cycle of myofibroblasts? Expert Opin Ther Targets 2015;19:1677-87. [PMID: 26690790 DOI: 10.1517/14728222.2015.1068758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
20 Alfonso-Rodríguez CA, Garzón I, Garrido-Gómez J, Oliveira AC, Martín-Piedra MÁ, Scionti G, Carriel V, Hernández-Cortés P, Campos A, Alaminos M. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease. PLoS One 2014;9:e112457. [PMID: 25379672 DOI: 10.1371/journal.pone.0112457] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
21 Viil J, Maasalu K, Mäemets-Allas K, Tamming L, Lõhmussaar K, Tooming M, Ingerpuu S, Märtson A, Jaks V. Laminin-rich blood vessels display activated growth factor signaling and act as the proliferation centers in Dupuytren's contracture. Arthritis Res Ther 2015;17:144. [PMID: 26018562 DOI: 10.1186/s13075-015-0661-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
22 Könneker S, Broelsch GF, Krezdorn N, Dastagir K, Kuhbier JW, Paprottka FJ, Vogt PM. Multiple Recurrences in Aggressive Forms of Dupuytren's Disease-Can Patients Benefit from Repeated Selective Fasciectomy? Plast Reconstr Surg Glob Open 2017;5:e1247. [PMID: 28280681 DOI: 10.1097/GOX.0000000000001247] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]